United States Food & Beverage Reservations open Page created Nov 16, 2026

List of FDA GRAS Notices for Precision Fermentation Proteins

FDA GRAS notices for proteins made by engineered microbes — animal-free whey, casein, egg-white, lactoferrin, heme and sweet proteins — with notifier, host organism, intended use and FDA response, for teams screening partners or investments in precision fermentation.

Fields we plan to include

Notifier (company)
GRN number
Protein / substance
Production host organism and strain
FDA response
Date of closure
Intended use and use levels
Protein class (dairy, egg, heme, sweet, bioactive)
Notifier address and country
Resubmission of earlier GRN
Link to notice and FDA letter

Data Preview

* Free sample rows, unverified and may contain errors. This list isn't for sale yet.
NotifierGRNSubstanceHost organism
Clara Foods Co.Source967Soluble egg-white proteinKomagataella phaffii strain GSD-1209
Motif FoodWorks, Inc.Source1001Myoglobin preparationPichia pastoris
TurtleTree Inc.Source1219Recombinant bovine lactoferrin isolateKomagataella phaffii M020
Bon Vivant SASSource1241β-lactoglobulinAspergillus oryzae
Onego Bio, Inc.Source1249OvalbuminTrichoderma reesei ATCC 13631

Estimated ~60 entries. If people reserve it, we'll try to compile it (we can't compile every list).

* No charge now. Purchase is optional.

Reading FDA GRAS notices for precision fermentation proteins

Precision fermentation uses an engineered microorganism — usually a yeast such as Komagataella phaffii (formerly Pichia pastoris) or a filamentous fungus such as Trichoderma reesei — to secrete a single target protein that was originally found in milk, eggs, meat or a sweet-tasting fruit. In the United States, most of these ingredients reach the market through the voluntary GRAS (Generally Recognized as Safe) notification program run by FDA's Human Foods Program rather than through a food additive petition.

Why the GRAS inventory is hard to use for this sector

FDA publishes every filed notice in its GRAS Notice Inventory, identified by a GRN number. The inventory describes each substance in free text, but it is not tagged by production method. A recombinant β-lactoglobulin sits next to plant extracts, fibres and probiotic strains, and the host organism only appears inside the substance description or the notice document itself. Producing a clean view of the precision fermentation pipeline therefore means reading each entry and separating recombinant food proteins from the much larger group of fermentation-derived enzymes and processing aids.

What a notice record tells you

ElementWhy it matters
GRN numberStable reference used in FDA letters, investor materials and later resubmissions.
Substance and host strainIdentifies the protein and the production organism; a new host or strain usually requires its own notice.
Intended useThe food categories and use levels the safety conclusion covers. Uses outside that scope are not covered by the letter.
NotifierThe company that filed — sometimes a contract manufacturer or ingredient partner rather than the consumer brand.
FDA response“No questions”, “ceased to evaluate at the notifier's request”, or “does not provide a basis”; pending notices have no letter yet.

Protein classes seen in the inventory

  • Whey proteins — β-lactoglobulin and α-lactalbumin produced in fungi or yeast, aimed at sports nutrition, beverages and dairy analogues.
  • Caseins — αS1-, β- and κ-casein, which are needed to form micelles for cheese-like texture; several casein notices are still listed as pending.
  • Egg proteins — ovalbumin, ovomucoid and soluble egg-white protein for baking, binding and clear beverages.
  • Bioactive milk proteins — lactoferrin, where use levels are low and the price per kilogram is high.
  • Heme proteins — soy leghemoglobin and myoglobin used for colour and flavour in meat analogues; colour uses may also need a color additive listing.
  • Sweet proteins — brazzein, thaumatin and monellin variants intended as high-intensity sweeteners.

Due diligence points

  1. Match the exact strain and intended use in the notice to the product you plan to source or invest in; a “no questions” letter does not transfer to a different host or process.
  2. Check whether the notice is a resubmission of an earlier GRN, which often signals that FDA raised questions the first time.
  3. Look at the date of closure and the FDA response together: a notice that ceased to be evaluated, or is still pending, gives a partner no FDA letter to rely on.
  4. Remember that GRAS status covers the United States only; the EU and UK treat these proteins as novel foods that need a separate authorisation, and other markets run their own reviews.
A GRAS “no questions” letter is FDA's response to the notifier's own safety conclusion. It is not an approval, and it does not cover labelling, allergen declarations or claims.

Frequently Asked Questions

Q.Is GRAS notification mandatory before selling a recombinant protein in the US?

No. The GRAS notification program is voluntary, and companies can self-affirm GRAS status. Many precision fermentation companies still file a notice because food manufacturers, retailers and investors look for an FDA response letter before committing to an ingredient.

Q.Why do some ingredients have more than one GRN?

A new GRN is typically filed when a company changes the production host or strain, expands the intended uses, or resubmits after an earlier notice was withdrawn or ceased. Impossible Foods' GRN 737 for soy leghemoglobin, for example, is a resubmission of GRN 540.

Q.Does a US GRAS letter allow sale in the EU or UK?

No. Proteins produced by precision fermentation are treated as novel foods in the EU and UK and need a separate authorisation there; a US GRAS letter has no legal effect outside the United States.

Q.Which host organisms are most common in these notices?

Yeasts of the species Komagataella phaffii (formerly Pichia pastoris) appear frequently as hosts for dairy, egg and heme proteins, alongside filamentous fungi such as Trichoderma reesei and Aspergillus oryzae. Bacterial hosts such as Escherichia coli appear in some casein notices.

Q.Can I buy the list now?

Not yet. Sample rows are free. We try to compile lists that people reserve (we can't compile every list). If we do, we'll email everyone who reserved it a purchase link (buying is optional). If we don't, nothing happens and you're never charged.

Q.What does it cost?

Sample rows are free. A list is $49, paid only if we compile it and you decide to buy. There is no free trial or subscription.